Mexican Health Chief Backs Drug Imports

20 April 1997

Mexico's Minister of Health, Juan Ramon de la Fuente, has said that thegovernment will eliminate barriers to imports into the country of foreign-made drugs which could be useful in combating Mexico's three major current public health problems, which he identified as AIDS, the resurgence of cholera and atmospheric pollution.

The government has also announced major increases in public health projects to expand basic health care services throughout the country. The MoH's 1997 budget has been increased by 32.4% to 14 billion pesos ($1.77 billion), and that of the Mexican Social Security Institute has gone up 22% to 21 billion pesos.

President Ernesto Zedillo Ponce de Leon said the massive increase in expenditure was "indispensable." Major efforts this year will include the decentralization of public health care, disease prevention, action on air and water pollution, deregulation of the medical industry, a boost for research, increased attention to family planning and prevention efforts in the area of common diseases.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight